«
New cystic fibrosis research takes aim at deadly pathogen.»
«Unsuspected characteristics of
new cystic fibrosis drugs found, offering potential paths to more effective therapies.»
Not exact matches
The families of two children with
cystic fibrosis who need
new lungs but were ineligible for adult organs have successfully used the courts and public opinion to get their daughter and son on the
ALBANY — The 26th Annual Stair Climb to benefit the
Cystic Fibrosis Foundation of Northeastern
New York will take place 6 to 9 p.m. Thursday at the Corning Tower, Empire State Plaza.
Fundamental understanding of basic biology has set the stage for
new treatments for
cystic fibrosis
Rogers designed a
new set of processes and techniques to develop the porcine model of
cystic fibrosis, but he soon realized those processes could have a much wider impact.
«How bacteria survive in oxygen - poor environments: Discovery could inform development of
new therapies for
cystic fibrosis infections.»
People with an uncommon form of
cystic fibrosis started gaining weight and were better able to breathe than their untreated counterparts after just two weeks on an experimental drug, according to a study published November 2 in The
New England Journal of Medicine.
Appearing alongside the heads of five of NIH's 27 institutes and centers, Collins instead offered examples of how NIH research has led to
new drugs for
cystic fibrosis and cancer treatments that help the immune system fight tumors.
A
new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and
cystic fibrosis.
The
new research investigated the effectiveness of MSC therapy in a mouse model of chronic inflammatory lung disease, which reflects some of the essential features of diseases such as COPD and
cystic fibrosis.
Like Gilead, which aims to develop treatments for HIV / AIDS, hepatitis B and C, influenza, pulmonary arterial hypertension, and
cystic fibrosis, other top employers accentuate the positive aspects of the life science industry by performing their R&D in entirely
new areas.
«Potential
new treatments for Toxoplasma - induced pneumonia and
cystic fibrosis.»
In lab experiments using tissue samples cultured from
cystic fibrosis patients, scientists at the UNC School of Medicine and the UNC Marsico Lung Institute have shown that a
new CF drug counteracts the intended beneficial molecular effect of another CF drug.
New research has discovered a link between a vital pumping system that does not function correctly in people with
cystic fibrosis and the parasite Toxoplasma.
«Protein structure could unlock
new treatments for
cystic fibrosis.»
Lisa Harris, of Dalton High School in
New York City, won this year's top Siemens prize for individuals — a $ 100,000 college scholarship — for developing a new method to detect carriers of a gene responsible for cystic fibros
New York City, won this year's top Siemens prize for individuals — a $ 100,000 college scholarship — for developing a
new method to detect carriers of a gene responsible for cystic fibros
new method to detect carriers of a gene responsible for
cystic fibrosis.
Served up in a fresh
new design, this issue explores flexible electronics that could change the shape of medicine, grassroots efforts to beat
cystic fibrosis, and how Hollywood is going transhuman.
We hope this leads to the ability to design, study and test
new therapies for every patient on their own cells in the lab, leading to
new treatments and breakthroughs in personalized medicine for individuals with a variety of lung diseases, including
cystic fibrosis,» explained lead author Katherine McCauley, a PhD student at BUSM.
Researchers have developed a
new approach for growing and studying cells they hope one day will lead to curing lung diseases such as
cystic fibrosis through «personalized medicine.»
Cystic fibrosis patient Els van der Heijden received a
new drug combination based on organoid tests.
Vertex scientists and our collaborators are working on
new medicines to cure or significantly advance the treatment of hepatitis C,
cystic fibrosis, epilepsy and other life - threatening diseases.
A multi-drug resistant infection that can cause life - threatening illness in people with
cystic fibrosis (CF) and can spread from patient to patient has spread globally and is becoming increasingly virulent, according to
new research published today in the journal Science.
When the gene for
cystic fibrosis (CF) was discovered 25 years ago, hopes ran high that
new treatments were just around the corner.
The Adult
Cystic Fibrosis Centre at Papworth Hospital, Cambridgeshire, has led the development and implementation of
new infection control policies to reduce the risk of transmission, now adopted across the UK and elsewhere.
New research has identified new molecules that could help in the fight to prevent diseases caused by faulty ion channels, such as cystic fibros
New research has identified
new molecules that could help in the fight to prevent diseases caused by faulty ion channels, such as cystic fibros
new molecules that could help in the fight to prevent diseases caused by faulty ion channels, such as
cystic fibrosis.
«
New molecules identified that could help in the fight to prevent
cystic fibrosis.»
Substances produced by a harmful bacterium in the lungs of
cystic fibrosis patients may enhance the growth of other bacteria that, in turn, inhibit the harmful bacterium's biofilm, according to
new research published in PLOS Pathogens.
Substances produced by a harmful bacterium in the lungs of
cystic fibrosis patients may enhance the growth of other bacteria that, in turn, inhibit the harmful bacterium's biofilm, according to
new research.
One early success story is
cystic fibrosis: since the gene was identified in 1989, exceptional progress has been made in devising
new experimental treatments, including gene therapy trials.
Said Flask, «In this initial paper, we validated our
new methodology, opening the possibility for numerous follow - on application studies in cancer, genetic diseases such as
cystic fibrosis, and metabolic diseases such as diabetes.»
The decision is expected to delay the provision of nine other
new treatments and services by NHS England, including prosthetics for lower limb loss, hearing implants for children with auditory nerve problems, and drugs for some children with
cystic fibrosis.
Alton says that the UK
Cystic Fibrosis Trust, which had poured # 30 million into the research so far, told his team in late February that because donations are down, the charity can't fund the
new trial.
Kalydeco is already helping hundreds of people, according to Robert Beall, president of the
Cystic Fibrosis Foundation: «The drug opens
new doors that may help us find therapies for everyone with this terrible disease.»
This «remarkable era» has been driven by concerted efforts to improve care, as well as strong leadership among health care professionals treating people with the disease, and resources from the
Cystic Fibrosis Foundation, write David Stevens of the Dartmouth Institute for Health Policy and Clinical Practice in
New Hampshire and Bruce Marshall of the
Cystic Fibrosis Foundation.
New research comparing
cystic fibrosis patients in the United States and Canada showed that, although the patients» nutritional status and lung function improved in both countries over the period from 1990 to 2013, the rate of improvement was faster in the United States.
Calling their compound a
new therapeutic candidate for people with severe asthma and other chronic airway diseases, researchers say with additional research and development their discovery could lead to future clinical trials for asthma,
Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (COPD).
While we had previously found an effective treatment for those with the «celtic gene» this
new combination treatment has the potential to help roughly half of those with
cystic fibrosis, those who have two copies the F508DEL mutation.
«Potential
new drug target for
cystic fibrosis.»
«
New imaging technique shows effectiveness of
cystic fibrosis drug: Hyperpolarized helium MRI could aid in development of improved therapies for lung diseases.»
Researchers have identified two
new biological markers of
cystic fibrosis (CF), a genetic disease which affects children and young adults, leaving them with lifelong health complications including digestive problems and persistent lung infections.
Led by Dr. Samya Nasr, the U-M
Cystic Fibrosis Center participates in numerous research studies investigating the latest treatments for CF, focusing on adherence,
new therapies, and nutritional health.
However, thanks to screening and
new treatments, people with
cystic fibrosis can live into their 40s and longer.
The condition is more common than muscular dystrophy and
cystic fibrosis, but the development of
new therapeutic concepts is hindered by the fact that unlike muscular dystrophy and
cystic fibrosis, where a single mutated gene causing the disease is known, the entire human chromosome 21 (containing around 300 genes) still has to be dissected into individual gene - dose contributions to the DS symptoms.
More and more scientists are using the powerful
new gene - editing tool known as CRISPR / Cas9, a technology isolated from bacteria, that holds promise for
new treatment of such genetic diseases as
cystic fibrosis, muscular dystrophy...
A
new study shows that tumor suppressor PTEN helps fight lung infections when attached to a protein that is mutated in
cystic fibrosis.
Research into lung disease has yielded many life - changing results, such as the development of
new effective asthma treatment, the increased success of lung transplants, better treatments for
cystic fibrosis, and proving the link between smoking and lung cancer.
New biological treatments using antibodies or antagonists against receptors or inflammatory enzyme inhibitors (e.g. CXCR2 antagonists, phosphodiesterase - 4 inhibitors, endothelin receptor antagonists and kinase inhibitors) to suppress inflammatory pathways in diseases such as asthma, COPD, idiopathic pulmonary
fibrosis,
cystic fibrosis and pulmonary hypertension.
If further progress is to be made then infants with
cystic fibrosis or neuromuscular disease will require more attention with earlier intervention to improve the quality of life using
new targeted biological approaches [17].
Using translational research methods, the DZL seeks to jointly develop
new approaches for the prevention, diagnosis and therapy of serious lung diseases including asthma, chronic obstructive pulmonary disease (COPD),
cystic fibrosis, diffuse parenchymal lung disease (DPLD), endstage lung disease, lung cancer, pneumonia and acute lung injury, and pulmonary hypertension.